Abstract
Introduction
Autoimmune Polyglandular Syndrome (APS) are a group of disorders characterized by autoimmunity against two or more endocrine organs [1] . Premature Ovarian Failure (POF) due to autoimmunity may be a part of this syndrome which may severely compromise fertility. Three types of APS are described. Type I is rare and presents in childhood. It consists of mucocutaneous candidiasis, hypoparathyroidism and primary adrenal insufficiency presenting in that order. It is inherited in an autosomal recessive manner, has no HLA association and has an equal sex distribution. APS type III is ill defined and is the cooccurrence of autoimmune thyroid disease with two other autoimmune thyroid diseases with two other autoimmune disorders including diabetes mellitus Type I, pernicious anemia or a nonendocrine autoimmune disease in the absence of Addision's disease. APS type II occurs more frequently when compared to the other 2 varieties. Addison's disease is generally identified later and diabetes is the usual first condition to be diagnosed early because of its complications, as evidenced in the present case report. This paper reports a case of secondary amenorrhea which was ultimately found to have APS Type II which is a rare triad of Addison's disease, Hypothyroidism and Diabetes Mellitus with POF.
Case Report
Mrs A aged 34 years, married for 8 years presented with complaints of secondary amenorrhea since 6 years and mild dyspareunia and attacks of hot flushes. She attained menarche at the age of 11 years and since then her cycles had been regular with normal flow. She conceived spontaneously after one and a half years of marriage and after an uneventful antenatal period, delivered a healthy female baby by caesarean section. No history of postpartum hemorrhage and her puerperium was uneventful. Lactation was established immediately after delivery and she continued successful lactation for one year. In spite of discontinuation of breastfeeding menstruation did not resume. After two years of childbirth, she was evaluated for secondary amenorrhoea. Her serum levels of thyroid hormones were T3 -1.63 ng/ml (0.60-1.81 ng/ ml), T4 -8.5 µg/dl (5.5 -11.0 µg/ dl), TSH-38.9 mIU/ml (0.5 -5.0 µIU/ ml), FSH -100 IU/ml.
She was diagnosed as a case of hypothyroidism and was started on thyroid supplementation therapy with 50 mcg of levothyroxine daily before breakfast.
After one and a half months, she developed petechial skin rash on the arms and thighs and bleeding from gums. Her serological tests showed Platelet Count-15,000/ cu mm with a few Chromosomal analysis showed normal XX karyotype with no structural anomalies.
Bone mineral density test revealed a Z-score of -3.8 suggestive of osteoporosis.
As the FSH and LH were in the menopausal range a diagnosis of premature ovarian failure (POF) was made. She was advised to take 0.625mg of conjugated estrogen for 21 days and 2.5 mg of medroxyprogesterone for the last 10 days of the menstrual cycle. She had withdrawal bleeding. She had general wellbeing apart from cyclical bleeding with hormone replacement. She is followed at monthly intervals for the past 2 years. At present, the patient is on hormone replacement therapy with calcium and vitamin D supplementation, levothyroxine 100µgm once daily, Insulin therapy and corticosteroid replacement therapy.
She is having regular menstrual cycles and her premature menopausal symptoms have subsided.
Discussion
Our case appears to be a Type II variant of APS on the basis of the new proposed classification of Neufeld and Blizzard [1] . This Syndrome was originally described by APS Type II is a rather rare disease with an incidence of 1.4-4.5 cases in every 1,00,000
inhabitants. It affects mainly adult women, The mean age at presentation is 35 years [4, 5] . The female to male ratio is 3-4:1. It is associated with HLA-DR3 and/or HLA-DR4 haplotypes, and the pattern of inheritance is autosomal dominant with variable expressivity [6] . Other disorders associated with APS Type II include the following hypogonadism (usually autoimmune oophoritis) and hypopituitarism, idiopathic thrombocytopenic purpura, myasthenia gravis, Parkinson disease, vitiligo, alopecia and seronegative arthritis [7] . Unlike with APS Types I and III, autoimmune POF is more commonly encountered with APS type
II. An autoimmune response to steroidogenic enzymes and ovarian steroid cells appears to mediate the destruction of ovarian function [8] . A transvaginal sonography is more sensitive in identifying any remaining ovarian follicles. An ovarian biopsy may reveal lymphocytic infiltration of the ovary.
In the present case, the patient first manifested secondary amenorrhea and hypothyroidism.
Later she developed Idiopathic thrombocytopenic purpura, which is considered a minor component of APS Type II [9] . Later she had full expression of APS Type II when she was diagnosed as Addisons disease and Insulin dependent diabetes mellitus. There may be a discrepancy in the clinical expression of APS TypeII. Incomplete forms of APS Type II are also described [10] . Hence biochemical and immunological screening tests may be helpful in predicting the functional failure of endocrine organs in patients with APS type II. Also their first degree relatives should be screened for the component disease. Children of women with any one of the autoimmune disorder should be screened for other disorders [11] .
The pathogenesis of APS Type II is poorly understood. The postulated steps are as follows
1. Some degree of genetic susceptibility must exist.
2. The individual is exposed to an environmental trigger.
3. Next, a subclinical phase of active production of organ-specific antibodies occurs.
4. There is autoimmune activity and progressive glandular destruction. Still the individual is asymptomatic. warranted because responsiveness to gonadotrophin administration is not achieved [12] .
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